Overview
The polymerase chain reaction is a widely used method for DNA amplification. It produces hundreds of thousands to millions of copies of a certain DNA sequence. The polymerase chain reaction market is moving its attention away from macro-scale systems and toward micro-scale device development. During the forecast period, the polymerase chain reaction market is expected to expand due to rising usage of polymerase chain reaction in different diagnostic and research applications, rising research and development spending in gene therapy, and continuing technical progress in polymerase chain reaction.
The global polymerase chain reaction market was worth US$ 3.7 billion in 2017 and is anticipated to grow at an annual rate of 8.8 percent from 2017 to 2025.
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/1546
Drivers
The global polymerase chain reaction market is projected to grow as a result of a growing number of product debuts and partnerships during the forecast period.
The global polymerase chain reaction market’s major manufacturers are working to introduce enhanced and new PCR instruments and consumables that would allow for quick and simple nucleic acid multiplication.
In addition, prominent businesses are participating in a number of collaborations in order to broaden their geographical horizons and serve more patients. Righton, a Chinese in-vitro diagnostics business, and Akonni Biosystems Inc. inked a commercial partnership in March 2018, allowing Righton to sell Akonni’s TruDiagnosis and TruTip Nucleic Acid Purification Kits in China. The global polymerase chain reaction market is growing as a result of substantial organic and inorganic development strategies implemented by various leading players.
The global polymerase chain reaction market is growing due to the rising occurrence of chronic and infectious diseases over the forecast period. In 2015, the CDC (Centers for Disease Control and Prevention) reported 5,251 fatalities in the U.S. attributable to influenza illness. According to the WHO (World Health Organization), about 32,000 estimated tuberculosis fatalities and 3, 23,000 new tuberculosis cases were recorded in the European region in 2015.
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/1546
In the U.S., 16.8 million appointments to medical centers for infectious and parasitic illnesses were recorded in 2015, as per the National Ambulatory Medical Care Survey: 2015 data findings. As per the WHO (World Health Organization), there were around 555,318 new cancer cases recorded in the Middle East Region in 2012. By 2030, the region is projected to have the greatest proportional rise in cancer cases of any region in the globe, with 961,098 cases. According to the Cancer Atlas, over 1.1 million new cancer cases and 600,000 cancer deaths were reported in Latin America and the Caribbean in 2012, with lung cancer being the main cause of cancer mortality in both genders.
Restraints
Advances in research are resulting in the development of a variety of substitute nucleic acid amplification techniques, which might stymie the global polymerase chain reaction market’s expansion during the forecast period. DestiNA Genomics and Quanterix Corporation partnered in March 2018 to create a PCR-free microRNA detection technique with high specificity and ultra-sensitivity, therefore improving RNA biomarker identification.
Competitive Landscape
Major companies contributing in the global polymerase chain reaction market are bioMérieux, S.A., Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Danaher Corporation, Dickinson and Company, Becton, Takara Bio Inc., Abbott Laboratories, and Enzo Life Science, Inc.
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/1546
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Polymerase Chain Reaction Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Polymerase Chain Reaction Industry Impact
Chapter 2 Global Polymerase Chain Reaction Competition by Types, Applications, and Top Regions and Countries
2.1 Global Polymerase Chain Reaction (Volume and Value) by Type
2.3 Global Polymerase Chain Reaction (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Polymerase Chain Reaction Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Polymerase Chain Reaction Market Analysis
Chapter 6 East Asia Polymerase Chain Reaction Market Analysis
Chapter 7 Europe Polymerase Chain Reaction Market Analysis
Chapter 8 South Asia Polymerase Chain Reaction Market Analysis
Chapter 9 Southeast Asia Polymerase Chain Reaction Market Analysis
Chapter 10 Middle East Polymerase Chain Reaction Market Analysis
Chapter 11 Africa Polymerase Chain Reaction Market Analysis
Chapter 12 Oceania Polymerase Chain Reaction Market Analysis
Chapter 13 South America Polymerase Chain Reaction Market Analysis
Chapter 14 Company Profiles and Key Figures in Polymerase Chain Reaction Business
Chapter 15 Global Polymerase Chain Reaction Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
Continued….
Press Release: https://www.coherentmarketinsights.com/press-release/polymerase-chain-reaction-market-to-surpass-us-74-billion-by-2025-852
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837